Physician No program year No payments reported Source: CMS Open Payments, 2026 publication

Jun Kang

Dermatology Baltimore, MD

NPI 1174941900 CMS profile 7223652

601 N Caroline St Ste 8065, Baltimore, MD 21287

Open in the dashboard

General payments

None reported

Research payments

Paid to them · None reported

Ownership & investment interest

None reported

The CMS Open Payments record contains no reported payments to Jun Kang of Baltimore, MD.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

100

Median for Dermatology: 534

Drug cost

$467,944

Median for Dermatology: $67,151

Branded share of claims

84%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug	Type	Claims	Drug cost
Octagam Immun Globg(Igg)/Malt/Iga Ov50	Brand	20	$284,672
Saphnelo Anifrolumab-Fnia	Brand	35	$183,014
Sodium Chloride 0.9 % Sodium Chloride	Brand	17	$197
Diphenhydramine Hcl	Generic	16	$45
Ondansetron Hcl Ondansetron Hcl/Pf	Brand	12	$17

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$28,145

Medicare's payments for the services billed

Medicare patients

175

Average age 67

Services billed

486

103 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients	Relative to the most common	Share of patients
High blood pressure		74%
Arthritis		58%
Chronic kidney disease		36%
Ischemic heart disease		35%
Diabetes		33%
Depression		26%
Heart failure		25%
Atrial fibrillation		23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Other Dermatology in Maryland

Benjamin Lockshin

Dermatology · Silver Spring, MD

Shawn Kwatra

Dermatology · Baltimore, MD

Chesahna Kindred Weaver

Dermatology · Marriottsville, MD

Oanh Lauring

Dermatology · Nottingham, MD

Rebecca Kazin

Dermatology · Chevy Chase, MD

Susan Walker

Dermatology · Bethesda, MD

Related records

Dermatology in Maryland

Practitioners in the same specialty and state, ranked by reported value.

All Dermatology

Everyone recorded under this specialty, nationwide.

Doctors in Maryland

Every practitioner in the state with a reported payment.

How to read this page

What each amount means, and what it does not mean.

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.